Lv42
560 积分 2025-05-07 加入
Efficacy and Safety of CHO(E)P Plus Novel Agents in Treatment-Naïve Peripheral T-Cell Lymphoma: Systemic Review and Meta-Analyses
4小时前
已关闭
Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma
1天前
已完结
Molecular heterogeneity of CD30+ peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study
1天前
已完结
Primary large B-cell lymphomas of immune-privileged sites
1天前
已完结
A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma
14天前
已完结
Therapeutic challenges in peripheral T-cell lymphoma
16天前
已完结
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)
16天前
已完结
A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy
20天前
已完结
Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma
20天前
已关闭
Golidocitinib: First Approval
20天前
已完结
皖公网安备34019202002308
